Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Cutaneous Lupus Erythematosus”

26 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 26 results

Not applicableStudy completedNCT01923415
What this trial is testing

A Non-drug Study Profiling Cutaneous Lupus

Who this might be right for
Lupus Erythematosus, CutaneousLupus Erythematosus, SystemicLupus Erythematosus, Discoid
Janssen Research & Development, LLC 29
Testing effectiveness (Phase 2)Ended earlyNCT01466725
What this trial is testing

A Research Study to Assess if CC-930 is Safe in Treating Subjects With Discoid Lupus Erythematosus

Who this might be right for
Discoid Lupus
Celgene 5
Large-scale testing (Phase 3)Looking for participantsNCT07355218
What this trial is testing

Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

Who this might be right for
Systematic Lupus ErythematosusCutaneous Lupus Erythematosus
EMD Serono Research & Development Institute, Inc. 202
Testing effectiveness (Phase 2)Ended earlyNCT05879718
What this trial is testing

Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms.

Who this might be right for
Lupus Erythematosus, SystemicLupus Erythematosus, Cutaneous
Pfizer 8
Testing effectiveness (Phase 2)Study completedNCT01597050
What this trial is testing

Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions

Who this might be right for
Lupus Erythematosus, DiscoidLupus Erythematosus, Systemic
Rigel Pharmaceuticals 54
Large-scale testing (Phase 3)Study completedNCT01551069
What this trial is testing

Multicenter Study Assessing the Efficacy & Safety of Hydroxychloroquine Sulfate in Patients With Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus With Active Lupus Erythematosus Specific Skin Lesion

Who this might be right for
Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus
Sanofi 103
Testing effectiveness (Phase 2)Study completedNCT03134222
What this trial is testing

Study to Evaluate Safety and Efficacy of Filgotinib and Lanraplenib in Females With Moderately-to-Severely Active Cutaneous Lupus Erythematosus (CLE)

Who this might be right for
Cutaneous Lupus Erythematosus
Gilead Sciences 47
Large-scale testing (Phase 3)Enrolling By InvitationNCT06044337
What this trial is testing

A Long-Term Extension Study to Learn More About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus

Who this might be right for
Subacute Cutaneous Lupus ErythematosusChronic Cutaneous Lupus Erythematosus
Biogen 306
Not applicableStudy completedNCT01858792
What this trial is testing

A Pooled Analysis of the HGS1006-C1056 (BLISS-52) and HGS1006-C1057 (BLISS-76) Studies

Who this might be right for
Lupus Erythematosus, Discoid
Human Genome Sciences Inc., a GSK Company 1
Early research (Phase 1)Ended earlyNCT01470313
What this trial is testing

A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus

Who this might be right for
Cutaneous Lupus Erythematosus
Pfizer 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT04857034
What this trial is testing

Evaluate Efficacy and Safety of Deucravacitinib in Participants With Active Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE)

Who this might be right for
Lupus Erythematosus, DiscoidLupus Erythematosus, Subacute Cutaneous
Bristol-Myers Squibb 74
Large-scale testing (Phase 3)Active Not RecruitingNCT05531565
What this trial is testing

A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus

Who this might be right for
Subacute Cutaneous Lupus ErythematosusChronic Cutaneous Lupus Erythematosus
Biogen 450
Large-scale testing (Phase 3)Looking for participantsNCT07332481
What this trial is testing

Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease

Who this might be right for
Systemic Lupus Erythematosus (SLE)Cutaneous Lupus Erythematosus (CLE)
EMD Serono Research & Development Institute, Inc. 202
Not applicableEnded earlyNCT01559155
What this trial is testing

Role of Proteasomes in a Dermatological Autoimmune Disease: Bullous Pemphigoid

Who this might be right for
Pemphigoid, BullousPemphigusLupus Erythematosus, Cutaneous
Centre Hospitalier Universitaire de Nīmes 14
Testing effectiveness (Phase 2)Looking for participantsNCT07694336
What this trial is testing

Quinacrine in Participants With Cutaneous Lupus Erythematosus

Who this might be right for
Cutaneous Lupus Erythematosus (CLE)
Victoria Werth 24
Testing effectiveness (Phase 2)Looking for participantsNCT07260877
What this trial is testing

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus

Who this might be right for
Cutaneous Lupus Erythematosus (CLE)Systemic Lupus ErythematosusSLE+2 more
Ventus Therapeutics U.S., Inc. 24
Early research (Phase 1)Study completedNCT01845740
What this trial is testing

Phase Ib Study of SC Milatuzumab in SLE

Who this might be right for
Lupus Erythematosus, CutaneousLupus Erythematosus, DiscoidLupus Erythematosus, Systemic+2 more
Gilead Sciences 22
Early research (Phase 1)Ended earlyNCT02428309
What this trial is testing

Autologous Polyclonal Tregs for Lupus

Who this might be right for
Lupus Erythematosus, CutaneousLupus Erythematosus, DiscoidLupus Erythematosus, Systemic
National Institute of Allergy and Infectious Diseases (NIAID) 1
Testing effectiveness (Phase 2)Ended earlyNCT03958955
What this trial is testing

Efficacy and Safety of Delgocitinib Cream in Discoid Lupus Erythematosus.

Who this might be right for
Discoid Lupus Erythematosus
LEO Pharma 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT06980805
What this trial is testing

Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Cutaneous Lupus Erythematosus (CLE)

Who this might be right for
Subacute Cutaneous Lupus ErythematosusChronic Cutaneous Lupus Erythematosus
Immunovant Sciences GmbH 56
Next Page